FLT3 and acute lymphoblastic leukemia: Although we observed that FLT3 expression was downregulated in predicted dexamethasone-resistant ALL patient samples, in vitro development of dexamethasone resistance in cell lines using long-term culture retained FLT3 expression in resistant cells and even selected for oncogenic FLT3 mutations5.